Striatum specific protein, Rhes regulates AKT pathway

Neurosci Lett. 2012 Jul 19;521(2):142-7. doi: 10.1016/j.neulet.2012.05.073. Epub 2012 Jun 6.

Abstract

The Rhes/RASD2 GTPase complex is involved in dopamine D1/D2 receptor-mediated signaling and behavior. This GTP binding protein belongs to the RAS superfamily, along with Dexras1/RASD1, and is primarily expressed in the striatum. RASDs differ from typical small GTPases as they have an extended C-terminal tail of roughly 7 kDa. Previously, it has been shown that dopamine depletion reduces Rhes mRNA expression in the brain. Here we show that Rhes interacts with p85, the regulatory subunit of PI3K. Specifically, the C-terminal unique tail region of Rhes is responsible for this interaction. The interaction between p85 and the C-terminal region of Rhes is enhanced upon growth factor treatment in vitro, while AKT translocation to the membrane is facilitated in the presence of Rhes or the Rhes-p85 complex. These findings suggest that Rhes is a novel striatal regulator of the AKT-mediated pathway in the striatum.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cell Membrane / metabolism
  • Class Ia Phosphatidylinositol 3-Kinase / metabolism
  • Corpus Striatum / metabolism*
  • Epidermal Growth Factor / pharmacology
  • Fibroblast Growth Factors / pharmacology
  • GTP-Binding Proteins / genetics
  • GTP-Binding Proteins / metabolism*
  • HEK293 Cells
  • Humans
  • Insulin-Like Growth Factor I / pharmacology
  • PC12 Cells
  • Phosphorylation
  • Platelet-Derived Growth Factor / pharmacology
  • Protein Transport
  • Proto-Oncogene Proteins c-akt / physiology*
  • Rats
  • Signal Transduction
  • Transfection

Substances

  • Platelet-Derived Growth Factor
  • Fibroblast Growth Factors
  • Epidermal Growth Factor
  • Insulin-Like Growth Factor I
  • Class Ia Phosphatidylinositol 3-Kinase
  • Proto-Oncogene Proteins c-akt
  • GTP-Binding Proteins
  • Rasd2 protein, rat